Advanced stage prostate cancer patients experience 20 year survival rates with surgery

by Anil Kumar



Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found. Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland.

Previously, patients found to have cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy.

The researchers presented their findings during the American Urological Association Annual Meeting in Washington.

"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," says R. Jeffrey Karnes, M.D., of Mayo Clinic's Department of Urology. "We have confirmed that patients diagnosed with locally advanced prostate cancer can enjoy a long, cancer-free interval."

The 80 percent survival rate for cT3 diagnoses at 20 years compares to 90 percent for cT2, or cancer confined to the prostate. This long-term follow-up of patients who underwent surgery between 1987 and 1997 is an important advance in understanding the quality outcomes for cT3 patients. The study sample included patients diagnosed and operated on between 1987 and 1997. Ongoing research will examine contemporary data.


(Anil Kumar -- sub-editor compiled and published Advanced stage prostate cancer patients experience 20 year survival rates with surgery at HealthNewsTrack on May 16, 2011 sourced from Mayo Clinic - http://www.mayoclinic.org/)

Prostate Cancer - recent articles and current news stories:

- IMRT Radiation optimal for localized prostate cancer
- Circumcision may protect you against prostate cancer
- PSA test helps predicting biopsy need and low risk prostate cancer
- More aggressive treatment not necessary for men with a family history of prostate cancer
- Alpharadin improved survival in advanced prostate cancer patients

Most related articles:

- Advanced stage prostate cancer patients experience 20 year survival rates with surgery
- Refusal to prostate cancer surgery may impact survival - 10.9
- Prostate surgery improves younger prostate cancer patients survival - 10.2
- Prostate cancer vaccine Provenge prolongs survival - 8.9
- Men with wives more likely to be screened for prostate cancer - 8.7

More related articles:

- Prostate cancer, Survival rate, Surgery, cT3 prostate cancer, Radical prostatectomy, Prostate gland, Radiation, Hormone treatment, Prostatectomy
- Prostate surgery improves younger prostate cancer patients survival - 33.9
- Prostate cancer family history has no impact on treatment - 24.7
- Prostatectomy effective in men with aggressive prostate cancer - 23.2
- Refusal to prostate cancer surgery may impact survival - 23

Prostate Cancer related articles:

- Prostate cancer risk from heavy drinking - 6
- High insulin level increases prostate cancer risk - 5.9
- Circumcision may protect you against prostate cancer - 5.8
- Smoking may increase risk of prostate cancer recurrence - 5.7
- Prostate biopsy is not always necessary after raised PSA levels - 5.7

Prostate Cancer article/news source:

Read more health articles from Mayo Clinic and health articles from USA.

Prostate Cancer - search related terms:

Hormone treatment, Prostate cancer, Prostate gland, Prostatectomy, Radiation, Radical prostatectomy, Surgery, Survival rate, cT3 prostate cancer,
Prostate Cancer books,

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.11